Ransoming Israel’s Chance for Peace

Hamas and Hezbollah are bound to read the Gilad Shalit exchange as a sign of Israel’s weakness and as a promise of its imminent capitulation. In these circumstances, Israel's task is to boost Palestinian President Mahmoud Abbas, not weaken him, as it did in the Shalit deal.

MADRID – The exchange of prisoners between enemies is often a prelude to political reconciliation. Unfortunately, the recent exchange between Israel and Hamas, in which the Islamist organization gained the lion’s share of more than 1,000 prisoners in exchange for the Israeli soldier Gilad Shalit, does not augur well for the chances of an Israeli-Palestinian peace.

Contrary to appearances, the deal is not a reflection of both sides’ interest in beginning a political rapprochement that might lead to the end of the Gaza siege and other confidence-building measures. This exchange reveals quite the opposite – that both parties are committed to their core values of resistance and confrontation.

For Israel, recovering Shalit was its way to uphold an ethos of unity in times of war, and to fulfill the army’s promise to its conscripts (and their families) that no soldier, dead or alive, would ever be left behind. The message was that Israel must remain mobilized and alert in a hostile environment, and that its survival depends on the cohesion of its citizens’ army, as well as on solidarity with those sent into battle.

To continue reading, please log in or enter your email address.

To access our archive, please log in or register now and read two articles from our archive every month for free. For unlimited access to our archive, as well as to the unrivaled analysis of PS On Point, subscribe now.

required

By proceeding, you agree to our Terms of Service and Privacy Policy, which describes the personal data we collect and how we use it.

Log in

http://prosyn.org/Q0JgPxI;

Cookies and Privacy

We use cookies to improve your experience on our website. To find out more, read our updated cookie policy and privacy policy.